compounsing semaglutide ending Hims? Hers? It's Novo Nordisk's Market Now Compounded Semaglutide: Legal & Safe

Clinical studies have shown that individuals using semaglutide experience a significant average weight loss of 14.9% within a year, with about one-third achieving an even more remarkable weight reduction exceeding 20% (PubMed)

Inject air into the vial

Not for human consumption, medical use, diagnostic use, or therapeutic use

Dehydration can worsen vaginal dryness and irritation, and Ozempic-related side effects like nausea, vomiting, or diarrhea can increase fluid loss

Wegovy is a GLP-1 receptor agonist, which means it works by activating receptors in the body that control appetite and blood sugar levels

Your semaglutide weight loss results after 12 weeks become much more pronounced as you reach the 1.0 mg threshold and transition into the primary therapeutic window